Literature DB >> 22398284

Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression.

Alan Belicha-Villanueva1, Juan R Rodriguez-Madoz, Jad Maamary, Alina Baum, Dabeiba Bernal-Rubio, Maria Minguito de la Escalera, Ana Fernandez-Sesma, Adolfo García-Sastre.   

Abstract

Influenza A viruses containing the promoter mutations G3A/C8U in a given segment express increased levels of the corresponding viral protein during infection due to increased levels of mRNA or cRNA species. The replication of these recombinant viruses is attenuated, and they have an enhanced shedding of noninfectious particles and are incapable of antagonizing interferon (IFN) effectively. Our findings highlight the possibility of increasing influenza virus protein expression and the need for a delicate balance between influenza viral replication, protein expression, and assembly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398284      PMCID: PMC3347261          DOI: 10.1128/JVI.06384-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Interaction of influenza virus polymerase with viral RNA in the 'corkscrew' conformation.

Authors:  Ramon Flick; Gerd Hobom
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

2.  Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Authors:  Sabine Steidle; Luis Martínez-Sobrido; Markus Mordstein; Stefan Lienenklaus; Adolfo García-Sastre; Peter Stäheli; Georg Kochs
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure.

Authors:  K Klumpp; R W Ruigrok; F Baudin
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  Mutational analysis of influenza virus promoter elements in vivo.

Authors:  G Neumann; G Hobom
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

5.  Influenza virus evades innate and adaptive immunity via the NS1 protein.

Authors:  Ana Fernandez-Sesma; Svetlana Marukian; Barbara J Ebersole; Dorothy Kaminski; Man-Seong Park; Tony Yuen; Stuart C Sealfon; Adolfo García-Sastre; Thomas M Moran
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.

Authors:  Alina Baum; Ravi Sachidanandam; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

7.  Rescue of influenza A virus from recombinant DNA.

Authors:  E Fodor; L Devenish; O G Engelhardt; P Palese; G G Brownlee; A García-Sastre
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome.

Authors:  Nicole C Robb; Matt Smith; Frank T Vreede; Ervin Fodor
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

9.  Role of initiating nucleoside triphosphate concentrations in the regulation of influenza virus replication and transcription.

Authors:  Frank T Vreede; Hugh Gifford; George G Brownlee
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

10.  A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA.

Authors:  Helen M Wise; Agnes Foeglein; Jiechao Sun; Rosa Maria Dalton; Sheetal Patel; Wendy Howard; Emma C Anderson; Wendy S Barclay; Paul Digard
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more
  11 in total

1.  Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.

Authors:  GuanQun Liu; Hong-Su Park; Hyun-Mi Pyo; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

Review 2.  Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier.

Authors:  Benjamin Mänz; Martin Schwemmle; Linda Brunotte
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

3.  The ubiquitination of the influenza A virus PB1-F2 protein is crucial for its biological function.

Authors:  Ivan Košík; Margaréta Práznovská; Martina Košíková; Zuzana Bobišová; Jaroslav Hollý; Eva Varečková; František Kostolanský; Gustáv Russ
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

4.  A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.

Authors:  Sascha Young Kupke; Dietmar Riedel; Timo Frensing; Pawel Zmora; Udo Reichl
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential.

Authors:  Marc D Hein; Heike Kollmus; Pavel Marichal-Gallardo; Sebastian Püttker; Dirk Benndorf; Yvonne Genzel; Klaus Schughart; Sascha Y Kupke; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2020-12-04       Impact factor: 4.813

Review 6.  Virus-like Particles: Measures and Biological Functions.

Authors:  Tara Bhat; Amy Cao; John Yin
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

7.  Competition between influenza A virus genome segments.

Authors:  Ivy Widjaja; Erik de Vries; Peter J M Rottier; Cornelis A M de Haan
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

8.  Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo Applications.

Authors:  Monique I Spronken; Kirsty R Short; Sander Herfst; Theo M Bestebroer; Vincent P Vaes; Barbara van der Hoeven; Abraham J Koster; Gert-Jan Kremers; Dana P Scott; Alexander P Gultyaev; Erin M Sorell; Miranda de Graaf; Montserrat Bárcena; Guus F Rimmelzwaan; Ron A Fouchier
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

9.  Development of high-yield influenza A virus vaccine viruses.

Authors:  Jihui Ping; Tiago J S Lopes; Chairul A Nidom; Elodie Ghedin; Catherine A Macken; Adam Fitch; Masaki Imai; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

10.  A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine.

Authors:  Ruth Harvey; Rachel E Johnson; Kirsty MacLellan-Gibson; James S Robertson; Othmar G Engelhardt
Journal:  Influenza Other Respir Viruses       Date:  2014-08-02       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.